Drug facts
MoleculeGlipizide (Glucotrol XL)
Generics already compete: 12 makers on the market. 30 A-rated products from 12 makers substitute at the counter.
Glucotrol was first approved by the FDA on 05/08/1984 under NDA 017783; the application holder is Pfizer Inc. The Orange Book lists NDA 017783 as discontinued.
The latest NADAC for GLIPIZIDE 10 MG TABLET is $0.04 per unit (as of 10/28/2026).
Holder Pfizer IncApplication NDA 017783Approved 05/08/1984
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Glucotrol patent listed in the Orange Book Orange Book
02Competition
- Generics
- 12 generic makers Orange Book
- First generic approved
- 05/10/1994 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Glipizide profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.04 per unitGLIPIZIDE 10 MG TABLET, mid-priced of 3 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 12/17/2024Class II, Glipizide, Amerisource Health Services LLC FDA enforcement
04Product
- Application holder
- Pfizer Inc Orange Book
- Application
- NDA 017783 Orange Book
- First approved
- 05/08/1984 Orange Book
- Dosage forms
- tablet; tablet, extended release
- Routes
- oral
- Status
- NDA 017783 discontinued Orange Book
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.